• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Quantitative structure-pharmacokinetic relationships derived on antibacterial sulfonamides in rats and its comparison to quantitative structure-activity relationships.

作者信息

Seydel J K, Trettin D, Cordes H P, Wassermann O, Malyusz M

出版信息

J Med Chem. 1980 Jun;23(6):607-13. doi: 10.1021/jm00180a005.

DOI:10.1021/jm00180a005
PMID:6993682
Abstract

Quantitative structure-pharmacokinetic relationships have been derived for a series of substituted 2-sulfapyridines. Pharmacokinetic parameters, such as elimination rate constant (ke), clearance (Cl), and protein-binding constant (Kassoc), have been determined in rats. The observed variation is statistically significant, explained by changes in the lipophilic (deltaRm), electronic (pKa), and steric effects (I, ES) of the substituents. The obtained correlations are discussed with respect to the previously derived correlations for the antibacterial activity of these compounds. A scale up of the results opens up the possibility of a rational synthesis of highly active sulfonamides with special pharmacokinetic properties because lipophilicity influences strongly the pharmacokinetic properties, whereas no influence on the degree of antibacterial effect is observed. Steric substituent influence is opposite on specific binding to bacterial enzymes and unspecific binding to serum proteins.

摘要

相似文献

1
Quantitative structure-pharmacokinetic relationships derived on antibacterial sulfonamides in rats and its comparison to quantitative structure-activity relationships.
J Med Chem. 1980 Jun;23(6):607-13. doi: 10.1021/jm00180a005.
2
Quantitative relationships between structure and pharmacokinetic parameters using molecular connectivity chi indices I: Substituted 2-sulfapyridines.使用分子连接性χ指数I研究结构与药代动力学参数之间的定量关系:取代的2-磺胺吡啶类化合物
J Pharm Sci. 1984 Feb;73(2):237-40. doi: 10.1002/jps.2600730223.
3
Pharmacokinetics of a series of 6-chloro-2,3,4,5-tetrahydro-3-substituted-1H- 3-benzazepines in rats. Determination of quantitative structure-pharmacokinetic relationships.大鼠体内一系列6-氯-2,3,4,5-四氢-3-取代-1H-3-苯并氮杂䓬的药代动力学。定量构效关系的测定。
Drug Metab Dispos. 1988 May-Jun;16(3):367-72.
4
Quantitative structure--pharmacokinetic relationship of a series of sulfonamides in the rat.大鼠体内一系列磺胺类药物的定量构效关系。
Eur J Drug Metab Pharmacokinet. 1990 Jul-Sep;15(3):211-7. doi: 10.1007/BF03190206.
5
Structure-pharmacokinetics relationship of quaternary ammonium compounds. Correlation of physicochemical and pharmacokinetic parameters.季铵化合物的结构-药代动力学关系。物理化学参数与药代动力学参数的相关性。
Naunyn Schmiedebergs Arch Pharmacol. 1984 Dec;328(2):111-8. doi: 10.1007/BF00512059.
6
Structure-pharmacodynamic-pharmacokinetic relationships of steroidal neuromuscular blocking agents.甾体类神经肌肉阻滞剂的结构-药效学-药代动力学关系
Eur J Anaesthesiol Suppl. 1995 Sep;11:45-54.
7
Robust assessment of statistical significance in the use of unbound/intrinsic pharmacokinetic parameters in quantitative structure-pharmacokinetic relationships with lipophilicity.在亲脂性定量构效关系中使用非结合/内在药代动力学参数时对统计学显著性的稳健评估。
Drug Metab Dispos. 2000 Feb;28(2):103-6.
8
Clonidine and related analogues. Quantitative correlations.可乐定及相关类似物。定量相关性。
J Med Chem. 1976 Aug;19(8):1049-54. doi: 10.1021/jm00230a014.
9
Structure-pharmacokinetic relationships among the N1,N3-alkylxanthines in rats.
J Pharm Pharmacol. 1991 Apr;43(4):262-9. doi: 10.1111/j.2042-7158.1991.tb06680.x.
10
Biological activity of drugs. XI. Relation of structure to the bacteriostatic activity of sulfonamides. (2).药物的生物活性。十一、磺胺类药物抑菌活性与结构的关系。(2)
Chem Pharm Bull (Tokyo). 1970 Apr;18(4):708-14. doi: 10.1248/cpb.18.708.

引用本文的文献

1
Quantitative relationships between structure and pharmacokinetics of beta-adrenoceptor blocking agents in man.人体内β-肾上腺素受体阻滞剂的结构与药代动力学之间的定量关系。
J Pharmacokinet Biopharm. 1984 Jun;12(3):263-87. doi: 10.1007/BF01061721.
2
Protein binding of glycopeptide antibiotics with diverse physical-chemical properties in mouse, rat, and human serum.
J Pharmacokinet Biopharm. 1987 Feb;15(1):5-13. doi: 10.1007/BF01062935.
3
Prediction of hepatic first-pass metabolism and plasma levels following intravenous and oral administration of barbiturates in the rabbit based on quantitative structure-pharmacokinetic relationships.基于定量构效关系预测巴比妥类药物静脉注射和口服给药后家兔的肝首过代谢及血浆水平。
J Pharmacokinet Biopharm. 1988 Jun;16(3):279-301. doi: 10.1007/BF01062138.
4
Charge and lipophilicity govern the pharmacokinetics of glycopeptide antibiotics.电荷和亲脂性决定了糖肽类抗生素的药代动力学。
Antimicrob Agents Chemother. 1986 Mar;29(3):440-4. doi: 10.1128/AAC.29.3.440.
5
Quantitative structure--pharmacokinetic relationship of a series of sulfonamides in the rat.大鼠体内一系列磺胺类药物的定量构效关系。
Eur J Drug Metab Pharmacokinet. 1990 Jul-Sep;15(3):211-7. doi: 10.1007/BF03190206.
6
Relative lipophilicities and structural-pharmacological considerations of various angiotensin-converting enzyme (ACE) inhibitors.
Pharm Res. 1992 Nov;9(11):1480-6. doi: 10.1023/a:1015823315983.